Bausch + Lomb Corporation IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Bausch + Lomb Corporation | BLCO - NYSE |
$21.00-$24.00 | $18.00 | $18.50 | 35 million | 5/6/2022 |
| Morgan Stanley, Goldman Sachs, Citigroup, JP Morgan, Barclays, BofA Securities, Guggenheim Securities, Jefferies, Evercore, Wells Fargo, Deutsche Bank | ||||||
Co-Manager(s): DNB Markets, HSBC, Truist Securities, AmeriVet Securities, Loop Capital Markets, Ramirez & Co., R. Seelaus & Co., Siebert Williams Shank, Stern | ||||||
| Health Care | ||||||
Filing(s): Filed 2022-01-13 Updated Filing 2022-03-31 Terms Added 2022-04-28 | ||||||
Bausch + Lomb Corporation Quote & Chart - Click for current quote - BLCO
IPO Boutique aggregates information on public companies and private companies, such as "BLCO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Bausch + Lomb Corporation (adapted from Bausch + Lomb Corporation prospectus):
They are a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world—from the moment of birth through every phase of life.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world—from the moment of birth through every phase of life.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "BLCO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.